An audit of the use of Modafinil in clinical practice for the treatment of fatigue in multiple sclerosis patients

An audit of the use of Modafinil in clinical practice for the treatment of fatigue in multiple sclerosis patients

Bibliográfalaš dieđut
Váldodahkkit:	Littleton, E, Palace, J
Materiálatiipa:	Conference item
Almmustuhtton:	2005

Geahča maid

Modafinil for multiple sclerosis fatigue: does it work?
Dahkki: Littleton, E, et al.
Almmustuhtton: (2010)

Assessing the impacts of L-carnitine and modafinil on fatigue in Iraqi multiple sclerosis patients
Dahkki: Ahmed Hamza Al-Shammari, et al.
Almmustuhtton: (2023-01-01)

The use of modafinil for the treatment of fatigue in multiple sclerosis: A systematic review and meta‐analysis of controlled clinical trials
Dahkki: Shamas Ghazanfar, et al.
Almmustuhtton: (2024-07-01)

Reduced EDSS progression in multiple sclerosis patients treated with modafinil for three years or more compared to matched untreated subjects
Dahkki: Bibani, R, et al.
Almmustuhtton: (2012)

Reduced EDSS progression in multiple sclerosis patients treated with modafinil for three years or more compared to matched untreated subjects
Dahkki: Bibani, R, et al.
Almmustuhtton: (2012)

An approach to the identification of targets of autoantibodies in multiple sclerosis
Dahkki: Littleton, E, et al.
Almmustuhtton: (2004)

Towards defining antigenic targets for antibodies in multiple sclerosis
Dahkki: Littleton, E, et al.
Almmustuhtton: (2006)

Use of Modafinil in Psychiatric Disorders
Dahkki: Mehmet Hanifi Kokacya, et al.
Almmustuhtton: (2016-03-01)

New and old treatments for multiple sclerosis.
Dahkki: Palace, J
Almmustuhtton: (1998)

Modafinil for the treatment of fatigue in lung cancer: results of a placebo-controlled, double-blind, randomized trial.
Dahkki: Spathis, A, et al.
Almmustuhtton: (2014)

Modafinil for the treatment of fatigue in lung cancer: results of a placebo-controlled, double-blind, randomized trial
Dahkki: Spathis, A, et al.
Almmustuhtton: (2014)

An audit of the diagnostic usefulness of the NMO-IgG assay for neuromyelitis optica
Dahkki: Littleton, E, et al.
Almmustuhtton: (2006)

New treatments and azathioprine in multiple sclerosis.
Dahkki: Palace, J, et al.
Almmustuhtton: (1997)

Short- and Long-Term Efficacy of Modafinil at Improving Quality of Life in Stroke Survivors: A Post Hoc Sub Study of the Modafinil in Debilitating Fatigue After Stroke Trial
Dahkki: Thomas P. Lillicrap, et al.
Almmustuhtton: (2018-04-01)

Modafinil and Learning and Memory- Is there a Connection? Evaluation of the Effect of Modafinil on Learning and Memory in Wistar Rats
Dahkki: Mnnat Gill, et al.
Almmustuhtton: (2019-10-01)

The successful treatment of hypercapnic respiratory failure with oral modafinil
Dahkki: Parnell H, et al.
Almmustuhtton: (2014-04-01)

Comparison of effects of modafinil and caffeine on fatigue-vulnerable and fatigue-resistant aircrew after a limited period of sleep deprivation
Dahkki: Yara Q. Wingelaar-Jagt, et al.
Almmustuhtton: (2024-01-01)

Sociodemographic and Clinical Determinants of Fatigue in Multiple Sclerosis
Dahkki: Smaranda Maier, et al.
Almmustuhtton: (2023-10-01)

Modafinil-induced Fixed Drug Eruption
Dahkki: Girish Vasant Gaikwad, et al.
Almmustuhtton: (2012-01-01)

Reduction in excess daytime sleepiness by modafinil in patients with myotonic dystrophy.
Dahkki: Talbot, K, et al.
Almmustuhtton: (2003)

Positive effect of modafinil on daytime somnolence on patients with Myotonic Dystrophy
Dahkki: Talbot, K, et al.
Almmustuhtton: (2002)

Managing treatment fatigue in patients with multiple sclerosis on long-term therapy: the role of multiple sclerosis nurses
Dahkki: Crawford A, et al.
Almmustuhtton: (2014-08-01)

Modafinil-Induced Increases in Brain Dopamine Levels
Dahkki: J Gordon Millichap
Almmustuhtton: (2009-04-01)

Modafinil Trial in Attention Deficit Hyperactivity Disorder
Dahkki: J Gordon Millichap
Almmustuhtton: (2005-12-01)

Making the diagnosis of multiple sclerosis.
Dahkki: Palace, J
Almmustuhtton: (2001)

Modafinil does not reduce cocaine use in methadone-maintained individuals
Dahkki: Elise E. DeVito, et al.
Almmustuhtton: (2022-03-01)

Combination of modafinil and d-Amphetamine for the treatment of cocaine dependence: A preliminary investigation
Dahkki: Joy M Schmitz, et al.
Almmustuhtton: (2012-08-01)

Modafinil Induced Psychosis in a Patient with Bipolar 1 Depression
Dahkki: Alexander A. DiSciullo, et al.
Almmustuhtton: (2018-01-01)

A randomised controlled trial of modafinil for treatment of daytime somnolence in myotonic dystrophy
Dahkki: Talbot, K, et al.
Almmustuhtton: (2003)

Modafinil decreases anxiety-like behaviour in zebrafish
Dahkki: Adrian Johnson, et al.
Almmustuhtton: (2017-02-01)

Fatigue and Oropharyngeal Dysphagia in Patients with Multiple Sclerosis
Dahkki: Anna Alice dos Santos Leite, et al.
Almmustuhtton: (2020-04-01)

Efficacy of modafinil on fatigue and excessive daytime sleepiness associated with neurological disorders: a systematic review and meta-analysis.
Dahkki: Ping Sheng, et al.
Almmustuhtton: (2013-01-01)

Modafinil-excipient compatibility study using differential scanning calorimetry
Dahkki: Derar Omari, et al.
Almmustuhtton: (2023-01-01)

The UK Multiple Sclerosis database.
Dahkki: Palace, J, et al.
Almmustuhtton: (1999)

Fatigue in Multiple Sclerosis: (An update)
Dahkki: Hossein Zarei
Almmustuhtton: (2007-10-01)

Guidelines for differential diagnosis of suspected multiple sclerosis.
Dahkki: Palace, J
Almmustuhtton: (2009)

Effects of modafinil on emotional processing in first episode psychosis.
Dahkki: Scoriels, L, et al.
Almmustuhtton: (2011)

Factors affecting fatigue progression in multiple sclerosis patients
Dahkki: Dima Machtoub, et al.
Almmustuhtton: (2024-12-01)

Cataplexy as a side effect of modafinil in a patient without narcolepsy
Dahkki: Eduardo Lopes, et al.
Almmustuhtton: (2014-03-01)

Multiple sclerosis, fatigue and sleep disorders: beyond the clinical relapses
Dahkki: Tarso Adoni
Almmustuhtton: (2016-06-01)